Novartis earnings fall, CEO focuses on heart drug
July 21, 2015 at 07:44 AM EDT
Novartis saw sales fall in Q2, but it's optimistic about its pipeline, particularly heart disease drug Entresto, CEO Joe Jimenez says.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.